Description
Indication: Xigduo XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.
Mechanism of Action:
Dapagliflozin: Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by inhibiting the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion and lower blood glucose levels.
Metformin: Metformin is a biguanide antidiabetic medication. It works by decreasing the production of glucose in the liver and improving insulin sensitivity in the body’s tissues, thereby lowering blood sugar levels.
Dosage: Xigduo XR is available in tablet form for oral administration. The dosage prescribed by a healthcare provider may vary depending on the individual’s condition and response to treatment. It is typically taken once daily with food.
